ProRetina Therapeutics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Out of Business

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Liquidation

ProRetina Therapeutics General Information

Description

Developer of therapeutics and drugs designed to be used for the treatment of retinal dystrophies and degenerations. The company's products contain active ingredient, a neuroprotective agent which is highly effective in treating retinitis pigmentosa, a degenerative disease of genetic origins, enabling patients and healthcare institutions to avail cure to stop blindness in the adult age.

Contact Information

Website
www.proretina.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Plaza CEIN, 5
  • 31110 Noain
  • Spain
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Corporate Office
  • Plaza CEIN, 5
  • 31110 Noain
  • Spain

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProRetina Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Bankruptcy: Liquidation 30-Sep-2018 Completed Bankruptcy: Liquidation
5. Early Stage VC (Series A) 15-Aug-2013 Completed Generating Revenue
4. Grant Completed Startup
3. Seed Round 15-Sep-2012 Completed Startup
2. Early Stage VC 24-Sep-2010 $490K $3.88M Completed Startup
1. Early Stage VC 02-Apr-2010 $3.39M $3.39M Completed Startup
To view ProRetina Therapeutics’s complete valuation and funding history, request access »

ProRetina Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

ProRetina Therapeutics FAQs

  • When was ProRetina Therapeutics founded?

    ProRetina Therapeutics was founded in 2007.

  • Where is ProRetina Therapeutics headquartered?

    ProRetina Therapeutics is headquartered in Noain, Spain.

  • What is the size of ProRetina Therapeutics?

    ProRetina Therapeutics has 10 total employees.

  • What industry is ProRetina Therapeutics in?

    ProRetina Therapeutics’s primary industry is Pharmaceuticals.

  • Is ProRetina Therapeutics a private or public company?

    ProRetina Therapeutics is a Private company.

  • What is ProRetina Therapeutics’s current revenue?

    The current revenue for ProRetina Therapeutics is .

  • How much funding has ProRetina Therapeutics raised over time?

    ProRetina Therapeutics has raised $5.35M.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process